Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter and Conference Paper
Recombinant Interferon Alpha Plus Vinblastine in Metastatic Renal Cell Cancer: Updated Results
Recombinant interferon alpha (IFNα) has been shown to be effective in the treatment of metastatic renal cell cancer (RCC) with response rates in the order of 5%–15% [1–4]. In the hope of improving these result...